SNGX
Price:
$3.62
Market Cap:
$8.26M
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipro...[Read more]
Industry
Biotechnology
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
SNGX
According to Soligenix, Inc.’s latest financial reports and current stock price. The company's current ROE is -256.63%. This represents a change of 151.43% compared to the average of -102.07% of the last 4 quarters.
The mean historical ROE of Soligenix, Inc. over the last ten years is 4.59%. The current -256.63% ROE has changed -105.59% with respect to the historical average. Over the past ten years (40 quarters), SNGX's ROE was at its highest in in the December 2015 quarter at 11.24%. The ROE was at its lowest in in the December 2014 quarter at -1249.48%.
Average
4.59%
Median
-115.07%
Minimum
-642.05%
Maximum
42.77%
Discovering the peaks and valleys of Soligenix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 881.40%
Maximum Annual ROE = 42.77%
Minimum Annual Increase = -577.10%
Minimum Annual ROE = -642.05%
Year | ROE | Change |
---|---|---|
2023 | -243.45% | -143.59% |
2022 | 558.45% | -577.10% |
2021 | -117.05% | -75.24% |
2020 | -472.72% | -26.37% |
2019 | -642.05% | 353.06% |
2018 | -141.72% | 25.31% |
2017 | -113.09% | 157.77% |
2016 | -43.87% | -100.10% |
2015 | 42.77% | 881.40% |
2014 | 4.36% | 666.82% |
The current ROE of Soligenix, Inc. (SNGX) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
65.98%
5-year avg
-183.36%
10-year avg
4.59%
Soligenix, Inc.’s ROE is greater than Zura Bio Limited (-35.45%), greater than Apexigen, Inc. (-606.56%), greater than Phio Pharmaceuticals Corp. (-142.68%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-86.48%), less than Addex Therapeutics Ltd (105.53%), greater than Aceragen, Inc. (-46.48%), less than ERYTECH Pharma S.A. (6.80%), greater than Avenue Therapeutics, Inc. (-749.10%), greater than Palisade Bio, Inc. (-124.86%), less than ContraFect Corporation (403.13%), greater than Allarity Therapeutics, Inc. (-704.78%), less than CNS Pharmaceuticals, Inc. (428.91%), greater than Windtree Therapeutics, Inc. (-123.93%), greater than Dermata Therapeutics, Inc. (-197.44%), greater than Ensysce Biosciences, Inc. (-705.90%), less than Panbela Therapeutics, Inc. (545.45%), less than Baudax Bio, Inc. (54.54%),
Company | ROE | Market cap |
---|---|---|
-35.45% | $273.91M | |
-606.56% | $9.57M | |
-142.68% | $2.70M | |
2.18% | $1.88K | |
-86.48% | $43.51M | |
105.53% | $17.96M | |
-46.48% | $3.24M | |
6.80% | $47.38M | |
-749.10% | $3.17M | |
-124.86% | $3.76M | |
403.13% | $1.72M | |
-704.78% | $1.98M | |
428.91% | $3.73M | |
-123.93% | $6.12M | |
-197.44% | $1.84M | |
-705.90% | $8.42M | |
545.45% | $1.86M | |
54.54% | $8.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soligenix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Soligenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Soligenix, Inc.'s ROE?
How is the ROE calculated for Soligenix, Inc. (SNGX)?
What is the highest ROE for Soligenix, Inc. (SNGX)?
What is the 3-year average ROE for Soligenix, Inc. (SNGX)?
What is the 5-year average ROE for Soligenix, Inc. (SNGX)?
How does the current ROE for Soligenix, Inc. (SNGX) compare to its historical average?